DSIP analgesia research is one of the secondary research application areas for delta sleep inducing peptide that extends the DSIP research cluster beyond the sleep architecture and stress response literature. Pain modulation effects of DSIP have been documented in several rodent research models, and the underlying mechanisms involve opioid system modulation and direct effects on central pain processing pathways.
DSIP Analgesia Research: Pain Modulation Animal Model Studies
DSIP · Published April 14, 2026 · Updated May 18, 2026 · 7 min read
Quick Answer
DSIP analgesia research examines how Delta Sleep-Inducing Peptide modulates pain perception in rodent models, including interactions with opioid system signaling. Studies measure nociception thresholds, opioid receptor binding, and cross-pathway analgesic effects across standardized pain research protocols. For research use only, not for human consumption.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
- Pain Modulation and the Opioid System
- Rodent Pain Research Models
- Central Pain Processing Pathways
- Sleep Analgesia Interaction
- Stress Analgesia Interaction
- Cancer Pain Research Context
- Relationship to Other Pain Modulating Peptides
- Research Peptide Referenced
- Related Research Reading
- Related Research Articles
- Explore Related Products
- Frequently Asked Questions
- Glossary
Frequently Asked Questions
What is DSIP in research contexts?
+
DSIP (Delta Sleep-Inducing Peptide) is a synthetic nonapeptide first identified from cerebral venous blood of rabbits in 1977. It is studied in preclinical models for its effects on sleep architecture, the HPA axis, and neuroprotection.
How is DSIP studied for analgesia in animal models?
+
Pain modulation research uses thermal, mechanical, and chemical pain assays (hot plate, tail flick, formalin test) in rodents, examining DSIP effects alone and in combination with opioid system probes to characterize the analgesic profile.
What pain pathways does DSIP appear to modulate?
+
Published studies report DSIP interactions with the endogenous opioid system, including effects on enkephalin and beta-endorphin signaling, alongside non-opioid mechanisms involving HPA axis modulation and central neurotransmitter shifts.
Is DSIP approved for human use?
+
No. DSIP is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.
Glossary
Key terms used in this article.
- Nonapeptide
- A peptide consisting of nine amino acid residues; DSIP has the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu.
- Slow-Wave Sleep (SWS)
- The deepest stage of non-REM sleep, characterized by high-amplitude, low-frequency delta waves on EEG.
- HPA Axis
- The hypothalamic-pituitary-adrenal axis, a neuroendocrine system regulating the stress response via CRH, ACTH, and glucocorticoids.
- ACTH
- Adrenocorticotropic hormone, secreted by the anterior pituitary in response to CRH and stimulating glucocorticoid release from the adrenal cortex.
- Tail Flick Test
- A standard rodent thermal pain assay measuring latency to withdraw the tail from a heat source.
- Endogenous Opioid System
- The body's natural opioid signaling network including enkephalins, endorphins, and dynorphins acting on mu, delta, and kappa receptors.
More from the Blog
Continue exploring research insights and updates.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
